Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > Ireland & UK

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2628 | Ordered by Source (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
14M Genomics Ltd.. (12/16/14). "Press Release: 14M Genomics and Syncona Sign £12.5 Million Financing to Develop Cancer Genomic Diagnostics in Partnership with the Wellcome Trust Sanger Institute". 2014-12-16
14M Genomics Ltd.. (2/10/15). "Press Release: 14M Genomics and the Haematological Malignancy Research Network Collaborate on Clinical Genomic Profiling in Blood and Lymphatic Cancers". Cambridge. 2015-02-10
14M Genomics Ltd.. (3/10/15). "Press Release: 14M Genomics and the European Organisation for Research and Treatment of Cancer Collaborate on Genomic Profiling for Clinical Trials". Cambridge. 2015-03-10
14M Genomics Ltd.. (7/14/15). "Press Release: 14M Genomics Appoints Alan Schafer as Chief Executive Officer". Cambridge. 2015-07-14
4D Pharma plc. (12/8/15). "Press Release: Placing to Raise £30 Million by the Issue of 3,797,469 New Ordinary Shares at 790p per Share". 2015-12-08
4D Pharma plc. (2/10/16). "Press Release: Acquisition [of Tucana Health Ltd.]". 2016-02-10
4SC AG. (10/10/17). "Press Release: Resminostat Demonstrates Potential to Significantly Alleviate Itching in CTCL Patients". Planegg-Martinsried. 2017-10-10
AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA. 2016-10-27
AB Sciex (d/b/a Sciex). (10/28/15). "Press Release: Sciex Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine". Framingham, MA. 2015-10-28
AB Sciex (d/b/a Sciex). (11/09/17). "Press Release: New Method for the Detection of Fipronil Insecticide and Its Associated Metabolites in Eggs and Poultry Launched by Sciex". Warrington. 2017-11-09
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
AB Sciex (d/b/a Sciex). (6/13/16). "Press Release: The University of Manchester and Sciex to Open the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-13
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: The University of Manchester and Sciex Opened the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-28
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
AB Sciex. (11/8/13). "Press Release: AB Sciex’s European MASStastic Voyage Tour Brings Mobile Analytical Laboratory to Ireland’s Gathering of Leading Separation Scientists". Framingham, MA. 2013-11-08
AB Sciex. (2/3/15). "Press Release: AB Sciex Triple Quad 6500 LC/MS/MS Systems Enable New Levels of Sensitivity for Clinical Trials of Inhaled Drugs". Warrington. 2015-02-03
Abcam plc. (1/21/14). "Press Release: Abcam to Open Office in Shanghai, China". Cambridge. 2014-01-21
Abcam plc. (1/21/14). "Press Release: Half Year Trading Update". Cambridge. 2014-01-21
Abcam plc. (1/21/15). "Press Release: Abcam Acquires Firefly BioWorks to Expand Capabilities in Multiplex Analysis". Cambridge. 2015-01-21
Abcam plc. (1/21/15). "Press Release: Half Year Trading Update". Cambridge. 2015-01-21
Abcam plc. (11/4/13). "Press Release: Abcam Introduces Alexa Fluor Secondary Antibodies. New Range Offers Increased Choice for Multi-colour Staining". Cambridge. 2013-11-04
Abcam plc. (3/5/12). "Press Release: Entry into Definitive Agreement to Acquire Epitomics International Inc.". 2012-03-05
Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. 2018-04-26
Abcam plc. (4/8/13). "Press Release: Abcam Licenses Novel Technology from Columbia University for Neurobiological Research". Bristol & Cambridge. 2013-04-08
Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. 2017-05-18
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Abcam plc. (9/9/14). "Press Release: Abcam plc Announces Appointment of New CEO and Board Changes. Alan Hirzel Is Named Chief Executive Officer with Immediate Effect". Cambridge. 2014-09-09
Abcam plc. (9/9/14). "Press Release: Preliminary Results for Year Ended 30 June 2014". 2014-09-09
Abcodia Ltd.. (3/8/11). "Press Release: Collaborative Partners Sought for Abcodia, a Newly Launched Molecular Diagnostic Company". 2011-03-08
Abcodia Ltd.. (5/18/15). "Press Release: Abcodia Secures Funding of £5.25 million ($8m) to Launch the ROCA Test for the Early Detection of Ovarian Cancer". 2015-05-18
Abcodia Ltd.. (5/24/11). "Press Release: Abcodia Secures £1M Funding". 2011-05-24
Abcodia Ltd.. (6/16/11). "Press Release: Abcodia Appoints Dr Wendy Alderton as Director of Science". 2011-06-16
Abcodia Ltd.. (6/22/11). "Press Release: Abcodia Launches Colorectal Cancer Biomarker Initiative and Seeks International Collaborations". 2011-06-22
Abcodia Ltd.. (9/18/13). "Press Release: Abcodia Licenses the »Risk of Ovarian Cancer Algorithm« (ROCA) from Massachusetts General Hospital and Queen Mary, University of London". 2013-09-18
Abingdon Health Ltd.. (10/13/14). "Press Release: Abingdon Health Ltd Acquires Serascience Ltd and Raises £2.1m from Shareholders". Birmingham. 2014-10-13
Abingdon Health Ltd.. (10/16/17). "Press Release: Abingdon Health and Skannex Sign a Co-marketing Agreement". 2017-10-16
Abingworth LLP. (1/21/16). "Press Release: Abingworth Raises $105m for First Dedicated Clinical Co-Development Fund". 2016-01-21
Abingworth LLP. (2/28/14). "Press Release: Abingworth Raises £225m ($375m) in Its Tenth Life Sciences Fund". London. 2014-02-28
Abingworth LLP. (7/7/15). "Press Release: Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners". London. 2015-07-07
Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. 2018-07-09
Abingworth LLP. (9/16/16). "Press Release: GammaDelta Therapeutics Raises Seed Funding from Abingworth". 2016-09-16
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
Abivax S.A.. (2/11/16). "Press Release: Abivax to Participate in the Upcoming RBC Capital Markets 2016 Healthcare Conference in New York, and in the Credit Suisse Healthcare Conference in London". Paris. 2016-02-11
Ablatus Therapeutics Ltd.. (7/8/16). "Press Release: Ablatus Therapeutics Founded to Develop and Commercialise Pioneering Cancer Treatment. Spin Out Company Raises £500k Seed Funding". Cambridge & Norwich. 2016-07-08
Ablynx N.V.. (11/9/16). "Press Release: Ablynx to Present at the Jefferies London Healthcare Conference 2016". Ghent. 2016-11-09
Absolute Antibody Ltd.. (4/7/14). "Press Release: Absolute Antiobdy Receives £850K ($1.4M) Funding". Oxford. 2014-04-07
Abzena Ltd.. (5/23/14). "Press Release: PolyTherics and Antitope Form Abzena". London. 2014-05-23
Abzena Ltd.. (6/16/14). "Press Release: Abzena Announces Intention to Float [Not for US, Canada, Japan, South Africa, Ireland or Australia]". London. 2014-06-16
Abzena plc. (1/20/17). "Press Release: Abzena Signs New ThioBridge License Agreement". Cambridge. 2017-01-20
Abzena plc. (10/9/15). "Press Release: Adheron Therapeutics Is Acquired by Roche for Its Therapeutic Antibody. Antibody Fully Humanised Using Abzena’s Proprietary Technology". Cambridge. 2015-10-09
Abzena plc. (11/10/15). "Press Release: Appointment of Campbell Bunce as Senior Vice President, Scientific Operations". Cambridge. 2015-11-10
Abzena plc. (11/24/15). "Press Release: Half Year Results – Delivery, Acquisition and Growth". Cambridge. 2015-11-24
Abzena plc. (11/24/15). "Press Release: Placing to Raise £20 Million and Acquisition [Not for United States, Australia, Canada, Japan, the Republic of Ireland, the Republic of South Africa, et al.] ". Cambridge. 2015-11-24
Abzena plc. (6/8/15). "Press Release: Results for the Year Ended 31 March 2015". Cambridge, UK. 2015-06-08
Abzena plc. (7/2/18). "Press Release: Abzena and Telix Sign Strategic Manufacturing and Bioconjugation Agreement". Cambridge & Melbourne. 2018-07-02
Abzena plc. (8/16/18). "Press Release: Recommended Cash Offer for Abzena plc [NOT FOR RELEASE WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION]". 2018-08-16
Abzena plc. (8/16/18). "Press Release: Update on Partial Monetisation of Abzena Inside Portfolio". Cambridge. 2018-08-16
Abzena plc. (9/14/15). "Press Release: Acquisition of PacificGMP. Strategic Acquisition of GMP Biopharmaceutical Manufacturing Capability in the USA". Cambridge & San Diego, CA. 2015-09-14
Abzena plc. (9/14/17). "Press Release: Trading Update". Cambridge. 2017-09-14
Abzena plc. (9/19/17). "Press Release: Abzena Appoints Lotta Ljungqvist as Non-Executive Director". Cambridge. 2017-09-19
Acacia Pharma Group Ltd.. (2/5/18). "Press Release: Acacia Pharma Announces Its Intention to Launch an Initial Global Offering and to List Its Shares on Euronext Brussels [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN. 2018-02-05
Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN. 2018-03-02
Acacia Pharma Ltd.. (3/31/11). "Press Release: Acacia Pharma Closes $10 Million Investment Round". Cambridge. 2011-03-31
Acacia Pharma Ltd.. (9/3/13). "Press Release: Acacia Pharma Raises £15m ($23.5m) to Advance Clinical Development of Lead Products". Cambridge. 2013-09-03
Accovion GmbH. (11/5/20). "Press Release: Accovion GmbH Expands further into Strategic Markets. Accovion Launches Key Subsidiary in United Kingdom". Eschborn. 2011-05-20
Activiomics Ltd.. (11/22/12). "Press Release: Activiomics Signs Research Agreement with Kyowa Hakko Kirin as Part of Its Strategic Partnership with BioFocus". 2012-11-22
Activiomics Ltd.. (12/6/10). "Press Release: Activiomics Signs Technology Agreement with UCB". 2010-12-06
Activiomics Ltd.. (3/10). "Presentation: Introduction to Activiomics. (March 2010) Non-confidential". London. 2010-03-01
Activiomics Ltd.. (3/14/11). "Press Release: Biomarker Specialist Activiomics Receives Investment from IP Group plc. Investment in Queen Mary, University of London Spin-out to Fund Growth Strategy". 2011-03-14
Activiomics Ltd.. (3/27/12). "Press Release: Biomarker Specialist Activiomics Appoints Dr Trevor Nicholls as Non-executive Chairman". London. 2012-03-27
Activiomics Ltd.. (4/13/10). "Press Release: Activiomics, a New Spin-out from Queen Mary University London, Signs Commercial Agreement with GSK". 2010-04-13
Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London. 2013-09-30
Adaptimmune Ltd.. (1/7/13). "Press Release: Adaptimmune Announces Exclusive License with Life Technologies Corporation on Proprietary Manufacturing Process for T Cell Therapy Using Its Modified T Cell Receptors". Oxford & Philadelphia, PA. 2013-01-07
Adaptimmune Ltd.. (11/20/13). "Press Release: Adaptimmune Appoints Dr Jonathan Knowles as Chairman of the Board". Oxford & Philadelphia, PA. 2013-11-20
Adaptimmune Ltd.. (12/10/13). "Press Release: Adaptimmune Announces Interim Results from a Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma". Oxford & Philadelphia, PA. 2013-12-10
Adaptimmune Ltd.. (3/25/14). "Press Release: Adaptimmune Announces Award of £2.1m from the Biomedical Catalyst Fund". Oxford & Philadelphia, PA. 2014-03-25
Adaptimmune Ltd.. (3/26/14). "Press Release: Adaptimmune Announces Full-time Appointment of James Noble as Chief Executive Officer". Oxford & Philadelphia, PA. 2014-03-26
Adaptimmune Ltd.. (3/4/15). "Press Release: Adaptimmune Strengthens Management Team with Key Executive Hires". Oxford & Philadelphia, PA. 2015-03-04
Adaptimmune Ltd.. (6/2/14). "Press Release: Adaptimmune Enters Strategic Cancer Immunotherapy Collaboration with GlaxoSmithKline to Develop and Commercialise Novel Cell-based Therapies". Oxford & Philadelphia, PA. 2014-06-02
Adaptimmune Ltd.. (9/25/14). "Press Release: Adaptimmune Secures $104 Million Series A Financing. Company Will Use Funding to Advance Programmes in Multiple Cancer Indications". Oxford & Philadelphia, PA. 2014-09-25
Adaptimmune Therapeutics plc. (1/4/18). "Press Release: Paul Stead Joins Adaptimmune as Vice President of Business Development". Philadeliphia, PA & Oxford. 2018-01-04
Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 Billion Target Cell Dose". Philadeliphia, PA & Oxford. 2018-01-08
Adaptimmune Therapeutics plc. (1/8/18). "Press Release: Adaptimmune Announces Two Manufacturing Achievements on Its Way to Become the First Fully Integrated TCR T-cell Therapy Company". Philadeliphia, PA & Oxford. 2018-01-08
Adaptimmune Therapeutics plc. (10/12/16). "Press Release: Adaptimmune Provides Update on Clinical Study Evaluating Its SPEAR T-Cell Therapy Targeting NY-ESO-1 in Ovarian Cancer". Philadeliphia, PA & Oxford. 2016-10-12
Adaptimmune Therapeutics plc. (10/13/15). "Press Release: Adaptimmune Reports Full Fiscal Year 2015 Financial Results". Philadeliphia, PA & Oxford. 2015-10-13
Adaptimmune Therapeutics plc. (10/23/17). "Press Release: Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations". Philadeliphia, PA & Oxford. 2017-10-23
Adaptimmune Therapeutics plc. (10/6/15). "Press Release: Adaptimmune Announces New Research and Development Facility in Oxfordshire". Oxford & Philadelphia, PA. 2015-10-06
Adaptimmune Therapeutics plc. (10/9/15). "Press Release: Adaptimmune Growth Leads to Long-term Expansion Plans in Philadelphia. Company Selects The Navy Yard as Site for U.S. Headquarters and Base for Clinical and Manufacturing Operations". Philadeliphia 2015-10-09
Adaptimmune Therapeutics plc. (11/10/16). "Press Release: Adaptimmune Reports Third Quarter 2016 Financial Results". Philadeliphia, PA & Oxford. 2016-11-10
Adaptimmune Therapeutics plc. (11/12/15). "Press Release: Adaptimmune to Participate in the Jefferies Autumn 2015 Global Healthcare Conference". Philadeliphia, PA & Oxford. 2015-11-12
Adaptimmune Therapeutics plc. (11/13/15). "Press Release: Adaptimmune Reports First Quarter Financial Results for Fiscal Year 2015-16". Philadeliphia, PA & Oxford. 2015-11-13
Adaptimmune Therapeutics plc. (11/24/15). "Press Release: Adaptimmune Initiates Phase I / II trial Evaluating its Affinity Enhanced T-Cell Therapy Targeting NY-ESO-1 in Patients with the Most Common Type of Lung Cancer". Oxford & Philadelphia, PA. 2015-11-24
Adaptimmune Therapeutics plc. (11/5/15). "Press Release: Adaptimmune Announces Data from Clinical Study of NY-ESO Affinity Enhanced T-Cell Therapy in Synovial Sarcoma at the 2015 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)". Philadel 2015-11-05
Adaptimmune Therapeutics plc. (12/1/15). "Press Release: Adaptimmune and Universal Cells Announce Collaboration to Develop Allogeneic T-Cell Therapies". Philadeliphia, PA & Oxford. 2015-12-01
Adaptimmune Therapeutics plc. (2/2/16). "Press Release: Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration". London, Philadelphia, PA & Oxford. 2016-02-02
Adaptimmune Therapeutics plc. (2/3/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-02-03
Adaptimmune Therapeutics plc. (2/9/16). "Press Release: U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma". Philadeliphia, PA & Oxford. 2016-02-09
Adaptimmune Therapeutics plc. (3/13/17). "Press Release: Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results". Philadeliphia, PA & Oxford. 2017-03-13
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] – Putting Information into Context 600x60px

» top